Xavier Serres
Papers
1
Total Citations
30
H-Index
1
About
Xavier Serres is a pioneering researcher in the field of interventional oncology, with a primary focus on non-invasive tumor ablation technologies. His most significant contribution is his leadership in the #HOPE4LIVER single-arm pivotal trial, which evaluated histotripsy—a groundbreaking non-thermal, non-invasive focused ultrasound therapy that mechanically liquefies tissue—for the treatment of primary and metastatic liver tumors. This landmark 2025 study, already garnering 30 citations, demonstrated the safety and 1-year clinical efficacy of histotripsy, positioning it as a potential paradigm shift in liver cancer management. Serres’ work bridges the gap between diagnostic ultrasound and therapeutic intervention, offering patients a needle-free, radiation-free alternative to traditional surgery or thermal ablation. His research is characterized by rigorous clinical trial design and a commitment to translating novel physics-based therapies into practical, patient-centered treatments. As histotripsy moves toward broader clinical adoption, Serres’ foundational trial data will remain essential reading for oncologists, radiologists, and biomedical engineers seeking to understand the future of non-invasive solid tumor treatment.
Research Focus
Key Achievements
Top Papers
- 1